NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.
Also ASCO to release abstracts to members prior to annual meeting.
Advisors suggest NCI establish sarcoma research consortium.
Lung cancer screening trial reaches accrual goal of 50,000.
Markison leaving Bristol-Myers, two others promoted in reorganization.
Wilding named director, Univ. of Wisconsin Cancer Center.
NABCO to close June 30.
This month’s 8-page Business & Regulatory Report included in this issue.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access









